The most direct way to find a clinical trial is through ClinicalTrials.gov, a free database run by the U.S. government that lists over 400,000 studies worldwide. But it’s not the only option, and knowing how to search effectively makes the difference between a frustrating experience and actually finding a trial that fits your situation. Here’s how to navigate the process from start to finish.
Start With ClinicalTrials.gov
ClinicalTrials.gov is the largest and most comprehensive trial database available. You can search by condition, treatment, keyword, or a combination of all three. The site also lets you filter by location using your city, state, zip code, or country, so you can find studies within a reasonable distance.
The most important filter is recruitment status. You want studies marked “Recruiting” or “Not yet recruiting,” since those are the ones still accepting participants. Studies labeled “Active, not recruiting” are already running but have filled their spots. “Enrolling by invitation” means the researchers are selecting from a predetermined group, so you can’t apply directly. Filtering out completed, terminated, and withdrawn studies right away saves you time.
You can also narrow results by study type. Interventional studies (the ones most people picture when they think of clinical trials) test a specific drug, device, or procedure. Observational studies track health outcomes without assigning any treatment. Expanded access programs provide experimental treatments to patients with serious conditions who don’t qualify for existing trials.
Disease-Specific Search Tools
For certain conditions, specialized search tools work better than a general database. The National Cancer Institute runs its own trial finder at cancer.gov, which searches NCI-funded trials across the United States and internationally, including studies at NCI-Designated Cancer Centers. If you’re looking for an oncology trial, this tool surfaces relevant options that might get buried in a broader search.
Other organizations maintain similar condition-specific databases. The American Heart Association, Alzheimer’s Association, and many rare disease foundations curate trial listings for their communities. These often include plain-language descriptions and contact information that make it easier to take the next step.
Finding Trials Outside the United States
If you live outside the U.S. or are willing to travel internationally, the WHO International Clinical Trials Registry Platform (ICTRP) pulls data from registries around the world. Its search portal at trialsearch.who.int covers studies registered across multiple countries and can surface trials that don’t appear on ClinicalTrials.gov. The platform’s goal is to provide a complete global view of ongoing health research, making it useful for conditions where cutting-edge treatment development may be happening in Europe, Asia, or elsewhere.
Trial Matching Services
If searching databases feels overwhelming, patient matching services can simplify the process. Platforms like Antidote let you answer a series of questions about your condition and health history, then show you trials in your area that you’re likely to qualify for. Some of these services also surface details that are hard to find elsewhere, like whether a trial offers financial compensation or uses a placebo group. These tools are free for patients; the trial sponsors pay to reach potential participants.
Your doctor can also be a matchmaker. Oncologists, neurologists, and other specialists often know about trials at their own institution or within their professional network. If you’re interested in a trial, bring it up directly. Many physicians won’t mention trials unless asked.
Understanding Trial Phases
Before you apply, it helps to understand what phase a trial is in, since this shapes both the experience and the level of risk involved.
- Phase I trials test a treatment in a small group of 20 to 80 people for the first time. The primary goal is assessing safety and identifying side effects, not measuring whether the treatment works.
- Phase II trials expand to 100 to 300 participants and begin evaluating whether the treatment is effective, while continuing to monitor safety.
- Phase III trials enroll 1,000 to 3,000 people and compare the new treatment against standard care. These generate the evidence needed for regulatory approval.
- Phase IV trials happen after a drug is already approved and available. Researchers track long-term safety and effectiveness in the general population.
Earlier-phase trials carry more uncertainty because less is known about the treatment. Later-phase trials offer more data on both risks and benefits but may randomly assign you to a control group that receives standard treatment instead of the experimental one.
How Eligibility Criteria Work
Every trial has two lists that determine who can join: inclusion criteria and exclusion criteria. Inclusion criteria describe the characteristics you need to have, such as a specific diagnosis, age range, or disease stage. Exclusion criteria describe characteristics that disqualify you, like certain other medical conditions, recent surgeries, or medications you’re currently taking.
These criteria exist to protect participant safety and ensure the study produces reliable results. A trial studying a lung disease might require participants to be over 40, have a confirmed diagnosis for at least a year, and be current or former smokers. It might exclude people with sleep apnea or other respiratory conditions that could complicate the data. Don’t take a rejection personally. Criteria are about the science, not about you as a patient. If one trial doesn’t fit, another with different requirements might.
Remote and Decentralized Trials
Not every trial requires you to travel to a research hospital for every visit. Decentralized clinical trials conduct some or all study activities outside a traditional research site. That could mean telemedicine check-ins, home visits from a local healthcare provider, or visits to a nearby lab instead of a distant medical center. Some trials ship investigational treatments directly to your home when the product is safe to use without direct oversight.
On ClinicalTrials.gov, look for keywords like “decentralized,” “virtual,” or “remote” in the study description. These trials are becoming more common, and they can make participation realistic if you live far from a major research center.
What Trials Cost (and Don’t Cost)
The experimental treatment itself is almost always provided at no cost by the trial sponsor. You won’t pay for the drug, device, or procedure being studied.
Routine medical care during the trial is a different story. This includes things like doctor visits, blood tests, and imaging scans that you’d normally receive as part of your regular care. Medicare covers these routine costs for beneficiaries enrolled in qualifying clinical trials, along with the cost of diagnosing and treating any complications that arise from participation. Most private insurers follow a similar model, though coverage varies by plan and state. What isn’t typically covered: services performed solely for data collection that aren’t part of your direct medical care, and items the sponsor customarily provides for free.
Some trials also cover travel expenses or offer stipends. This information isn’t always listed in the database entry, so ask the study coordinator directly.
What to Ask Before You Enroll
Once you find a trial that looks like a fit, you’ll speak with a study coordinator or investigator before making any commitment. Focus your questions on five areas: the study’s purpose and how long it lasts, the possible risks and benefits, what your day-to-day participation will look like, whether there are any costs you’ll be responsible for, and how your personal health information will be handled.
You should also ask whether the trial has been reviewed by an Institutional Review Board (IRB). This is an independent committee that evaluates the study’s design and safety protections before any participants are enrolled. All legitimate trials go through this review.
The Informed Consent Process
Before joining any trial, you’ll receive a detailed informed consent document. Federal regulations require this document to cover specific ground: the purpose of the research, how long you’ll participate, what procedures are involved, foreseeable risks and potential benefits, alternative treatments available to you, how your privacy will be protected, and who to contact with questions or if something goes wrong.
Critically, the document must state that participation is entirely voluntary. You can refuse to join without any penalty, and you can withdraw at any time without losing access to the care you’re otherwise entitled to. If the trial involves more than minimal risk, the consent form must explain whether compensation or medical treatment is available if you’re injured during the study. Read every page. Ask questions about anything that isn’t clear. Signing doesn’t lock you in forever; it means you understand what you’re agreeing to at that point.